Clearmind Medicine Inc
CMND
View Detailed Chart
2.740USD
+0.130+4.98%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
14.74MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+4.98%
5 Days
+3587.75%
1 Month
+1253.09%
6 Months
+218.60%
Year to Date
+98.55%
1 Year
+130.25%
View Detailed Chart
TradingKey Stock Score of Clearmind Medicine Inc
Currency: USD Updated: 2025-10-27Key Insights
Its valuation is considered undervalued, Institutional ownership is very high.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Clearmind Medicine Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Clearmind Medicine Inc Highlights
StrengthsRisks
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Undervalued
The company’s latest PE is -1.32, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 589.42K shares, decreasing 42.22% quarter-over-quarter.
Held by Joel Greenblatt
Star Investor Joel Greenblatt holds 344.52K shares of this stock.
Clearmind Medicine Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Clearmind Medicine Inc Info
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Ticker SymbolCMND
CompanyClearmind Medicine Inc
CEOZuloff-Shani (Adi)
Websitehttps://www.clearmindmedicine.com/
FAQs
What is the current price of Clearmind Medicine Inc (CMND)?
The current price of Clearmind Medicine Inc (CMND) is 2.740.
What is the symbol of Clearmind Medicine Inc?
The ticker symbol of Clearmind Medicine Inc is CMND.
What is the 52-week high of Clearmind Medicine Inc?
The 52-week high of Clearmind Medicine Inc is 87.200.
What is the 52-week low of Clearmind Medicine Inc?
The 52-week low of Clearmind Medicine Inc is 2.360.
What is the market capitalization of Clearmind Medicine Inc?
The market capitalization of Clearmind Medicine Inc is 14.74M.
What is the net income of Clearmind Medicine Inc?
The net income of Clearmind Medicine Inc is -5.25M.
Is Clearmind Medicine Inc (CMND) currently rated as Buy, Hold, or Sell?
According to analysts, Clearmind Medicine Inc (CMND) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Clearmind Medicine Inc (CMND)?
The Earnings Per Share (EPS TTM) of Clearmind Medicine Inc (CMND) is -0.759.
Related Instruments
+1.32%
-0.88%
+1.75%
+0.83%
+0.60%
+0.38%
+0.91%
+1.03%
+2.32%
+0.60%
+0.40%
+1.97%
+1.63%
+1.21%
+0.65%
+0.66%
+2.57%
0.00%
-0.44%
+1.06%
